Abdominal pain, a common complaint in clinical practice, poses diagnostic challenges due to its diverse etiologies. This article aims to provide a comprehensive approach to evaluating abdominal pain, focusing on history taking, physical examination, and judicious use of diagnostic tests.
Accurate history taking is pivotal in the assessment of abdominal pain. The clinician should note the onset, location, character, duration, and radiation of pain, along with associated symptoms. The patient's medical, surgical, and family history, as well as lifestyle factors, are also important.
A thorough physical examination can provide valuable clues. Inspection, palpation, percussion, and auscultation should be systematically performed. The presence of scars, distention, or discoloration may indicate specific conditions. Palpation can reveal tenderness, masses, or organomegaly, while auscultation assesses bowel sounds.
Diagnostic tests should be used judiciously, guided by history and examination findings. Routine tests include complete blood count, liver function tests, and urinalysis. Imaging studies such as ultrasound, CT scan, or MRI may be necessary. Endoscopic procedures can be considered for suspected gastrointestinal pathology.
Special considerations should be given to high-risk groups such as the elderly, pregnant women, and immunocompromised patients. In these populations, abdominal pain may present atypically or progress rapidly, necessitating a high index of suspicion and prompt intervention.
Abdominal pain evaluation requires a systematic approach incorporating detailed history, comprehensive physical examination, and judicious use of diagnostic tests. Recognizing the complexity of this symptom and understanding its potential etiologies are essential in formulating a precise diagnosis and management plan. Continued education and practice refinement are crucial in improving patient outcomes.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation